Liver injury and recovery following radiation therapy for hepatocellular carcinoma: insights from functional liver imaging [0.03%]
功能性肝影像介导的肝细胞癌患者放射治疗后肝脏损伤和恢复情况研究进展
Peter Zaki,Kanokphorn Thonglert,Smith Apisarnthanarax et al.
Peter Zaki et al.
Aim: A critical need for hepatocellular carcinoma (HCC) management is understanding how the liver recovers following radiotherapy (RT). We hypothesized that functional liver imaging with 99mTc-sulfur colloid (SC) SPECT/CT...
Night shift-induced circadian disruption: links to initiation of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and risk of hepatic cancer [0.03%]
夜班引起的昼夜节律紊乱与非酒精性脂肪肝/非酒精性脂肪肝炎的发病及肝癌风险的关系
Anjali Singh,Baby Anjum,Qulsoom Naz et al.
Anjali Singh et al.
The circadian system plays a crucial role in regulating metabolic homeostasis at both systemic and tissue levels by synchronizing the central and peripheral clocks with exogenous time cues, known as zeitgebers (such as the light/dark cycle)...
Massimiliano Cadamuro,Luca Fabris,Xuchen Zhang et al.
Massimiliano Cadamuro et al.
Cholangiocarcinoma (CCA), an aggressive tumor originating from both intra- and extra-hepatic biliary cells, represents an unmet need in liver oncology, as treatment remains largely unsatisfactory. A typical feature of CCA is the presence of...
Ethnic disparities in the epidemiology, treatment, and outcome of patients with hepatocellular carcinoma in the United States [0.03%]
美国肝细胞癌患者流行病学、治疗和结局的种族差异
Mohammad Saeid Rezaee-Zavareh,Jeff Liang,Ju Dong Yang
Mohammad Saeid Rezaee-Zavareh
There are significant ethnic disparities in incidence, tumor stage, curative therapy receipt, and survival among patients with hepatocellular carcinoma (HCC) in the US. While previous models had predicted an increasing trend in the incidenc...
Hepatocellular carcinoma in Pacific Islanders: comparison of Pacific Island-born vs. US-born [0.03%]
太平洋岛民的肝细胞癌：出生在太平洋岛屿与出生在美国的比较
Shelby K Yee,Brenda Y Hernandez,Sandi Kwee et al.
Shelby K Yee et al.
Aim: To describe demographic, clinical, and outcome differences in Pacific Island-born (PI-born) compared to US-born hepatocellular carcinoma (HCC) patients of Pacific Island ancestry within a clinical cohort in Hawaii. ...
Gut microbiome profiles associated with steatosis severity in metabolic associated fatty liver disease [0.03%]
与代谢相关脂肪性肝病肝细胞脂质蓄积程度相关的肠道菌群特征分析研究
Tien S Dong,Kayti Luu,Venu Lagishetty et al.
Tien S Dong et al.
Aim: The microbiome has been shown to be pivotal in the development of metabolic associated fatty liver disease (MAFLD). Few have examined the relationship of the microbiome specifically with steatosis grade. Therefore, o...
Claudia P Oliveira,Angelo Paredes,Mohammed Siddiqui et al.
Claudia P Oliveira et al.
Aim: To compare the phenotype of lean versus overweight (OW) and obese (OB) subjects with non-alcoholic fatty liver disease (NAFLD) across multiple continents. ...
Hepatocellular carcinoma in Hepatitis B and Human Immunodeficiency Virus coinfection in Africa: a focus on surveillance [0.03%]
非洲乙型肝炎和人类免疫缺陷病毒共感染的肝细胞癌：重点在于监测
Qian Wan,Chimaobi Anugwom,Hailemichael Desalegn et al.
Qian Wan et al.
Human immunodeficiency virus (HIV) and hepatitis-B virus (HBV) infections are weighty public health challenges, especially in the African continent. The direct carcinogenic effect of HBV means that it remains a potent cause of early-onset h...
Hepatocellular carcinoma surveillance: current practice and future directions [0.03%]
肝细胞癌的筛查：当前实践和未来方向
Joseph C Ahn,Yi-Te Lee,Vatche G Agopian et al.
Joseph C Ahn et al.
Hepatocellular carcinoma (HCC) is among the leading causes of cancer incidence and mortality worldwide. Surveillance of individuals with cirrhosis or other conditions that confer a high risk of HCC development is essential for early detecti...
Immunotherapy biomarkers for HCC: contemporary challenges and emerging opportunities [0.03%]
肝癌免疫治疗生物标志物：当前挑战与新兴机遇
Sandi Kwee,Xin Chen
Sandi Kwee